Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System

American Journal of Managed Care

Volumn 16, Issue 10, 2010, Pages 741-750

  Gellad, Walid F ^a,b,d   Good, Chester B ^a,b   Lowe, John C ^a,c   Donohue, Julie M ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; CHLORPROPAMIDE; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; INSULIN; LOVASTATIN PLUS NICOTINIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; PRAVASTATIN; REPAGLINIDE; ROSIGLITAZONE; ROSUVASTATIN; SIMVASTATIN; SITAGLIPTIN; TOLAZAMIDE; TOLBUTAMIDE;

AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; VETERAN;

CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ECONOMICS, PHARMACEUTICAL; HEALTH CARE COSTS; HEALTH EXPENDITURES; HOSPITALS, VETERANS; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LOGISTIC MODELS; ODDS RATIO; OUTPATIENTS; PRESCRIPTION DRUGS; STATISTICS, NONPARAMETRIC; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 78649477653     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wennberg JE, Cooper MM. The Dartmouth Atlas of Health Care in the United States. Chicago, IL: Center for Evaluative Clinical Sciences, Dartmouth Medical School, AHA Press; 1996.
2. Gawande A. The cost conundrum: what a Texas town can teach us about health care. New Yorker. June 1, 2009:36-44.
3. Fisher E, Goodman D, Skinner J, Bronner K; Dartmouth Institute for Health Policy and Clinical Practice. Health care spending, quality, and outcomes: more isn't always better. February 27, 2009. http://www.dartmouthatlas.org/ downloads/reports/Spending-Brief-022709.pdf. Accessed September 23, 2009.
4. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending, part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003;138(4):288-298.
5. Yasaitis L, Fisher ES, Skinner JS, Chandra A. Hospital quality and intensity of spending: is there an association? Health Aff (Millwood). 2009;28(4):w566-w572.
6. Sirovich B, Gallagher PM, Wennberg DE, Fisher ES. Discretionary decision making by primary care physicians and the cost of U.S. health care. Health Aff (Millwood). 2008;27(3):813-823.
7. Hartman M, Martin A, McDonnell P, Catlin A; National Health Expenditure Accounts Team. National health spending in 2007: slower drug spending contributes to lowest rate of overall growth since 1998 [published correction appears in Health Aff (Millwood). 2009;28(1) doi: 10.1377/hlthaff.28.1.246]. Health Aff (Millwood). 2009;28(1):246-261.
8. Aitken M, Berndt ER, Cutler DM. Prescription drug spending trends in the United States: looking beyond the turning point. Health Aff (Millwood). 2009;28(1):w151-w160.
9. Aspinall SL, Berlin JA, Zhang Y, Metlay JP. Facility-level variation in antibiotic prescriptions for veterans with upper respiratory infections. Clin Ther. 2005;27(2):258-262. (Pubitemid 40462021)
10. Cox ER, Motheral BR, Henderson RR, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics. 2003;111(2):237-243. (Pubitemid 36177138)
11. Dubois RW, Batchlor E, Wade S. Geographic variation in the use of medications: is uniformity good news or bad? Health Aff (Millwood). 2002;21(1):240-250.
12. Fultz SL, Good CB, Fine M. Increased costs of diabetes therapy not related to glycemic control at three Veterans Affairs medical outpatient clinics. P & T: a peer-reviewed journal for formulary management. 2004;29(8):500-506.
13. Gao J, Campbell J. Trend and variation of prescription drug cost in the veterans health-care system. Health Serv Manage Res. 2008; 21(1):14-22.
14. Krein SL, Hofer TP, Kerr EA, Hayward RA. Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res. 2002;37(5):1159-1180.
15. Lopez J, Meier J, Cunningham F, Siegel D. Antihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002. Am J Hypertens. 2004;17(12 pt 1):1095-1099.
16. Steinman MA, Yang KY, Byron SC, Maselli JH, Gonzales R. Variation in outpatient antibiotic prescribing in the United States. Am J Manag Care. 2009;15(12):861-868.
17. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(suppl 2):B10-B21.
18. Office of the Assistant Deputy Under Secretary for Health for Policy and Planning. VHA Enrollment, Patients and Expenditures. Washington, DC: US Dept of Veterans Affairs Intranet Site; 2008. Accessed September 1, 2009.
19. Department of Veterans Affairs. Pharmacy Benefits Management Services. July 2009. Accessed August 1, 2009.
20. Sales MM, Cunningham FE, Glassman PA, Valentino MA, Good CB. Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003. Am J Manag Care. 2005;11(2):104-112.
21. National Committee for Quality Assurance. HEDIS & quality measurement. 2009. http://www.ncqa.org/tabid/59/Default.aspx. Accessed April 10, 2009.
22. Jha AK, Perlin JB, Steinman MA, Peabody JW, Ayanian JZ. Quality of ambulatory care for women and men in the Veterans Affairs Health Care System. J Gen Intern Med. 2005;20(8):762-765. (Pubitemid 41141011)
23. Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):386-399.
24. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [published corrections appear in Lancet. 2008;371(9630):2084 and 2005;366(9494):1358]. Lancet. 2005;366(9493):1267-1278.
25. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326(7404):e1423.
26. Gellad WF, Detsky AS, Choudhry NK. Implications of recent clinical trials on pay-for-performance [published correction appears in Am J Health Syst Pharm. 2009;66(11):973]. Am J Health Syst Pharm. 2009;66(9):864-867.
27. Stefos T, LaVallee N, Holden F. Fairness in prospective payment: a clustering approach. Health Serv Res. 1992;27(2):239-261.
28. Yano EM, Wright S, Cuerdon T. Organizational complexity: does it reflect differences in structure and management process at individual VAMCs? In: HSR&D 2009 National Meeting Abstracts; February 11-13, 2009; Baltimore, MD.
29. Huang PY, Yano EM, Lee ML, Chang BL, Rubenstein LV. Variations in nurse practitioner use in Veterans Affairs primary care practices. Health Serv Res. 2004;39(4 pt 1):887-904.
30. Frank RG. Prescription drug prices: why do some pay more than others do? Health Aff (Millwood). 2001;20(2):115-128.
31. Gellad WF, Choudhry NK, Friedberg MW, Brookhart MA, Haas JS, Shrank WH. Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res. 2009;44(2 pt 1):606-617.
32. Redelmeier DA, Bell CM, Detsky AS, Pansegrau GK. Charges for medical care at different hospitals. Arch Intern Med. 2000;160(10):1417-1422.
33. Hellerstein JK. The importance of the physician in the generic versus trade-name prescription decision. RAND J Econ. 1998;29(1):108-136.
34. Ashton CM, Petersen NJ, Souchek J, et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999;340(1):32-39.
35. Asch SM, McGlynn EA, Hogan MM, et al. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med. 2004;141(12):938-945.
36. Greenfield S, Kaplan SH. Creating a culture of quality: the remarkable transformation of the Department of Veterans Affairs Health Care System. Ann Intern Med. 2004;141(4):316-318. (Pubitemid 39079295)
37. Kerr EA, Gerzoff RB, Krein SL, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med. 2004;141(4):272-281.
38. Good CB, Valentino M. Access to affordable medications: the Department of Veterans Affairs pharmacy plan as a national model. Am J Public Health. 2007;97(12):2129-2131. (Pubitemid 351194686)